Given Imaging Ltd. (GIVN)
-NasdaqGS 14.88 
0.35(2.30%) 4:00PM EDT
| Prev Close: | 15.23 |
|---|
| Open: | 14.74 |
|---|
| Bid: | 14.70 x 100 |
|---|
| Ask: | 15.29 x 100 |
|---|
| 1y Target Est: | 20.83 |
|---|
| Beta: | 1.04 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 14.58 - 15.09 |
|---|
| 52wk Range: | 12.14 - 19.48 |
|---|
| Volume: | 136,825 |
|---|
| Avg Vol (3m): | 67,302 |
|---|
| Market Cap: | 466.80M |
|---|
| P/E (ttm): | 34.52 |
|---|
| EPS (ttm): | 0.43 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Under $7 Stock May be Traders' Ticket to 50%-Plus ProfitsStreetAuthority Network(Wed, May 22)
- Given Imaging Study May Help Approval: Israel Overnightat Bloomberg(Tue, May 21)
- Given Imaging Announces New Data Showing ManoScan(R) High Resolution Manometry Improves Gastroenterologists' Ability to Detect and Diagnose GI Tract DisordersGlobeNewswire(Tue, May 21)
- Given Imaging Announces New Data Highlighting PillCam(R) COLON Comparability to Colonoscopy in Detecting AdenomasGlobeNewswire(Tue, May 21)
- InPlay: Given Imaging announces data confirming PillCam SB improves monitoring and management of Crohn's diseaseBriefing.com(Tue, May 21)
- Given Imaging Announces Data Confirming PillCam(R) SB Improves Monitoring and Management of Crohn's DiseaseGlobeNewswire(Tue, May 21)
- 3 Health Care Stocks Spiking on Big Volumeat TheStreet(Tue, May 21)
- Given Imaging Announces New European Study Evaluating PillCam(R) COLON versus CT-Colonography in Patients With Incomplete ColonoscopyGlobeNewswire(Mon, May 20)
- Details On Nokia’s New EOS, Given Imaging’s New Opportunities, and 3 More Hot Stocksat Wall St. Cheat Sheet(Mon, May 20)
- Given Imaging Announces New Data Confirming SmartPill(R) Improves Diagnosis and Clinical Management of Patients With Motility IssuesGlobeNewswire(Mon, May 20)
- This Forgotten Stock Could Kick Off a Big Rally Next WeekStreetAuthority Network(Thu, May 16)
- Oversold Conditions For Given Imaging (GIVN)at TheStreet(Thu, May 16)
- Given Imaging Announces Extensive Data From More Than 140 Abstracts to Be Presented at Digestive Disease Week(R) 2013GlobeNewswire(Mon, May 13)
- Investors Ride 5 Healthcare Earnings Rollercoaster Ridesat Wall St. Cheat Sheet(Sun, May 12)
- Given Imaging Goes Redat Motley Fool(Thu, May 9)
Key Statistics
| Forward P/E (1 yr): | 18.15 |
|---|
| P/S (ttm): | 2.66 |
|---|
| Ex-Dividend Date: | 20-Feb-09 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.57 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.16 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.09 |
|---|
Business Summary
Given Imaging Ltd. develops, manufactures, and markets diagnostic products for the visualization and detection of gastrointestinal tract disorders. It provides Given System, a proprietary wireless imaging system that uses PillCam capsules for visu...
View More